Mar 31, 2019

Enliven Therapeutics Q1 2019 Earnings Report

EPS
-$0.971
Research and Development Expenses
$3.56M
General and Administrative Expenses
$634K
Gross Profit
$0

Enliven Therapeutics

Enliven Therapeutics